21,145 Shares in Astera Labs, Inc. $ALAB Bought by Bearing Point Capital LLC

Bearing Point Capital LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 21,145 shares of the company’s stock, valued at approximately $3,518,000.

A number of other large investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in Astera Labs by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after purchasing an additional 84,365 shares during the period. Geode Capital Management LLC increased its position in shares of Astera Labs by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after acquiring an additional 104,935 shares during the period. State Street Corp boosted its stake in shares of Astera Labs by 9.1% during the 3rd quarter. State Street Corp now owns 2,339,451 shares of the company’s stock valued at $458,065,000 after purchasing an additional 195,992 shares in the last quarter. Amundi boosted its stake in shares of Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. Finally, Value Aligned Research Advisors LLC boosted its stake in shares of Astera Labs by 16.7% during the 3rd quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock valued at $269,881,000 after purchasing an additional 197,320 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $343.05 on Friday. The firm’s 50 day moving average price is $190.82 and its 200-day moving average price is $165.12. Astera Labs, Inc. has a 52-week low of $84.78 and a 52-week high of $354.53. The company has a market cap of $58.80 billion, a PE ratio of 231.79, a P/E/G ratio of 4.54 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same period in the previous year, the company earned $0.33 earnings per share. The firm’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently commented on ALAB shares. Rothschild & Co Redburn started coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Morgan Stanley boosted their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. UBS Group started coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective on the stock. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Finally, TD Cowen lifted their target price on shares of Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a report on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $233.75.

Insider Activity

In other news, CEO Jitendra Mohan sold 325,693 shares of the business’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. The trade was a 7.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the sale, the director directly owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,316,257 shares of company stock valued at $474,860,636 over the last three months. Insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.